BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7778720)

  • 1. [Adjuvant chemotherapy in the treatment of pharyngolaryngeal cancers in advanced stages].
    Alvarez Vicent JJ; Brandariz Castelo JA; Domingo Carrasco C; Mendiola C; Guerrero J; Cornejo M
    An Otorrinolaringol Ibero Am; 1995; 22(2):179-96. PubMed ID: 7778720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
    Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
    Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction chemotherapy and laryngeal preservation in pharyngolaryngeal carcinomas. Study of a 124 serie's patients and patient's follow up with laryngeal preservation].
    Bessède JP; Vinh D; Genet D; Khalifa N; Aubry K; Rhein B; Orsel S; Tubiana-Mathieu N; Clavère P
    Rev Laryngol Otol Rhinol (Bord); 2004; 125(2):81-8. PubMed ID: 15462166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H; Yamaguchi Y
    Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ preservation therapy for advanced-stage laryngeal carcinoma.
    Hoffman HT; McCulloch T; Gustin D; Karnell LH
    Otolaryngol Clin North Am; 1997 Feb; 30(1):113-30. PubMed ID: 8995140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of an organ conservation protocol in patients with locally advanced laryngeal tumours].
    León X; López M; García J; Quer M
    Acta Otorrinolaringol Esp; 2009; 60(3):176-85. PubMed ID: 19558903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of the combination of radiation and surgery in the treatment of invasive pharyngo-laryngeal carcinoma].
    Faucher A; Renaud-Salis JL; Mauruc B; Richaud P; Touchard J
    Ann Otolaryngol Chir Cervicofac; 1988; 105(7):539-42. PubMed ID: 3218823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transoral laser microsurgery in advanced carcinomas of larynx and pharynx].
    López-Álvarez F; Rodrigo JP; Llorente-Pendás JL; Suárez-Nieto C
    Acta Otorrinolaringol Esp; 2011; 62(2):95-102. PubMed ID: 21112575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of carcinoma of the pyriform sinus at Santa Creu I Sant Pau Hospital of Barcelona. The role of surgery].
    Quer M; Esteller E; León X; Orus C; Martínez V; Burgués J; de Andrés L; López Pousa A; Vega M; Guedea F
    An Otorrinolaringol Ibero Am; 1993; 20(5):459-78. PubMed ID: 8291663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
    Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
    Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
    Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
    Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
    Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transoral laser surgery for pharyngeal and pharyngolaryngeal carcinomas.
    Kutter J; Lang F; Monnier P; Pasche P
    Arch Otolaryngol Head Neck Surg; 2007 Feb; 133(2):139-44. PubMed ID: 17309982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laryngocele: clinical and therapeutic study of 60 cases].
    Matiño Soler E; Martínez Vecina V; León Vintró X; Quer Agustí M; Burgues Vila J; de Juan M
    Acta Otorrinolaringol Esp; 1995; 46(4):279-86. PubMed ID: 7546853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of radiotherapy in 117 cases of carcinoma of pyriform sinuses].
    Ramos Fernández J; Avilés Mañoso P; Martín Atienza R; Lozano Barriuso MA; Fernández-Vega M
    Acta Otorrinolaringol Esp; 1994; 45(3):185-90. PubMed ID: 8068362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined treatment for advanced laryngeal carcinoma].
    Ge JH; Zhao RL; Hu JL
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):20-3. PubMed ID: 15127563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.